3.48
price up icon3.26%   0.11
after-market 시간 외 거래: 3.48
loading
전일 마감가:
$3.37
열려 있는:
$3.46
하루 거래량:
85,700
Relative Volume:
1.07
시가총액:
$1.24B
수익:
$842.96M
순이익/손실:
$-185.63M
주가수익비율:
-6.6172
EPS:
-0.5259
순현금흐름:
$-228.52M
1주 성능:
-0.57%
1개월 성능:
-10.31%
6개월 성능:
-10.54%
1년 성능:
+1.75%
1일 변동 폭
Value
$3.4431
$3.52
1주일 범위
Value
$3.36
$3.52
52주 변동 폭
Value
$2.84
$5.6405

Evotec Se Adr Stock (EVO) Company Profile

Name
명칭
Evotec Se Adr
Name
전화
-
Name
주소
-
Name
직원
4,766
Name
트위터
Name
다음 수익 날짜
2025-04-17
Name
최신 SEC 제출 서류
Name
EVO's Discussions on Twitter

EVO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
EVO
Evotec Se Adr
3.48 1.20B 842.96M -185.63M -228.52M -0.5259
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
153.32 67.90B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.40 48.29B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.80 44.04B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
18.95 21.20B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
400.52 17.21B 2.99B 1.21B 1.13B 25.06

Evotec Se Adr Stock (EVO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-24 업그레이드 Deutsche Bank Sell → Hold
2024-10-07 다운그레이드 Jefferies Buy → Hold
2024-08-08 다운그레이드 Deutsche Bank Hold → Sell
2024-07-29 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2024-07-11 다운그레이드 Deutsche Bank Buy → Hold
2024-04-12 업그레이드 Deutsche Bank Hold → Buy
2024-01-18 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2023-06-23 업그레이드 Morgan Stanley Equal-Weight → Overweight
2023-06-16 다운그레이드 BofA Securities Buy → Neutral
2023-06-08 업그레이드 Citigroup Neutral → Buy
2023-04-04 업그레이드 Morgan Stanley Underweight → Equal-Weight
2022-12-09 개시 H.C. Wainwright Buy
2022-11-16 다운그레이드 Deutsche Bank Buy → Hold
2022-08-10 다운그레이드 Morgan Stanley Overweight → Underweight
2022-03-02 재개 Cowen Outperform
2022-01-07 재개 Citigroup Neutral
모두보기

Evotec Se Adr 주식(EVO)의 최신 뉴스

pulisher
Sep 01, 2025

Evotec Ag’s Earnings Call: Mixed Sentiments and Strategic Moves - TipRanks

Sep 01, 2025
pulisher
Aug 14, 2025

Evotec SE ADR earnings missed by $0.07, revenue fell short of estimates - Investing.com South Africa

Aug 14, 2025
pulisher
Aug 14, 2025

Evotec AG Reports Mixed H1 2025 Performance - TipRanks

Aug 14, 2025
pulisher
Aug 02, 2025

Evotec shares drop sharply after lowering 2025 revenue forecast - MSN

Aug 02, 2025
pulisher
Jul 30, 2025

Drug Discovery Platforms Market Size Expected to Reach USD 635.45 Million by 2034 - GlobeNewswire Inc.

Jul 30, 2025
pulisher
Jul 30, 2025

Evotec and Sandoz plan potential sale of Toulouse biologics site By Investing.com - Investing.com South Africa

Jul 30, 2025
pulisher
Jul 30, 2025

Evotec and Sandoz plan potential sale of Toulouse biologics site - Investing.com

Jul 30, 2025
pulisher
Jul 26, 2025

Evotec SE (EVO) Stock Forecasts - Yahoo Finance

Jul 26, 2025
pulisher
Jul 25, 2025

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union - Ariva

Jul 25, 2025
pulisher
Jul 22, 2025

SAP Quarterly Statement Q2 202522.07.25News - Ariva

Jul 22, 2025
pulisher
Jul 21, 2025

Evotec stock tumbles after slashing 2025 revenue guidance - Investing.com Australia

Jul 21, 2025
pulisher
Jul 21, 2025

Evotec stock tumbles after slashing 2025 revenue guidance By Investing.com - Investing.com Canada

Jul 21, 2025
pulisher
Jun 04, 2025

8 New 4-Star Stocks - Morningstar

Jun 04, 2025
pulisher
May 24, 2025

Evotec SE ADR (EVO) Strikes $4.73: The Risk Seems Worthwhile At This Price - Stocksregister

May 24, 2025
pulisher
May 07, 2025

Evotec SE ADR earnings missed by $0.03, revenue fell short of estimates - Investing.com Nigeria

May 07, 2025
pulisher
May 07, 2025

Evotec Ag Earnings Call: Mixed Sentiment Amid Growth - TipRanks

May 07, 2025
pulisher
May 07, 2025

Evotec AG Reports Q1 2025 Earnings and Strategic Progress - TipRanks

May 07, 2025
pulisher
Apr 28, 2025

Stock Information - Evotec

Apr 28, 2025
pulisher
Apr 24, 2025

Evotec shares surge 51% following InvestingPro’s undervalued signal By Investing.com - Investing.com

Apr 24, 2025
pulisher
Apr 18, 2025

Evotec SE ADR earnings beat by $0.08, revenue topped estimates - Investing.com Australia

Apr 18, 2025
pulisher
Apr 17, 2025

Evotec SE Reports Strong Q4 2024 and New Strategy - TipRanks

Apr 17, 2025
pulisher
Apr 17, 2025

Evotec Ag’s Earnings Call: Growth Amid Challenges - TipRanks

Apr 17, 2025
pulisher
Apr 17, 2025

Evotec: Management Streamlines Strategy to Refocus on Core Strengths Amid Biologics Momentum - Morningstar

Apr 17, 2025
pulisher
Dec 29, 2024

Evotec: Some Recovery Has Come, But Much More Is Expected - Seeking Alpha

Dec 29, 2024
pulisher
Nov 25, 2024

Markets Brief: Are Bank Stocks Expensive? - Morningstar

Nov 25, 2024
pulisher
Nov 22, 2024

Evotec SE withdraws acquisition offer - Investing.com

Nov 22, 2024
pulisher
Nov 15, 2024

Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid - Baystreet.ca

Nov 15, 2024
pulisher
Aug 23, 2024

Annual General Meeting - Evotec

Aug 23, 2024
pulisher
Aug 23, 2024

Investor Relations - Evotec

Aug 23, 2024
pulisher
Aug 14, 2024

Earnings call: Evotec SE revises 2024 outlook amid market challenges - Investing.com

Aug 14, 2024
pulisher
Aug 13, 2024

Dozens of US Stocks Are Newly Undervalued After Market Selloff - Morningstar

Aug 13, 2024
pulisher
Jun 06, 2024

Healthcare Sector - Morningstar

Jun 06, 2024
pulisher
May 23, 2024

Earnings call: Evotec SE Q1 2024 results show mixed performance amid challenges - Investing.com India

May 23, 2024
pulisher
Apr 24, 2024

Evotec: Still A Speculative Buy After A Significant Decline (NASDAQ:EVO) - Seeking Alpha

Apr 24, 2024
pulisher
Apr 18, 2024

Evotec and Variant Bio partner to develop fibrosis treatments - Investing.com

Apr 18, 2024
pulisher
May 17, 2023

Biosimilars Business News Recap: A New Partnership; Celltrion Wins Tenders - Center for Biosimilars

May 17, 2023

Evotec Se Adr (EVO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$29.94
price up icon 3.53%
$18.43
price up icon 5.50%
drug_manufacturers_specialty_generic RDY
$14.34
price up icon 1.34%
$10.50
price up icon 1.65%
$144.10
price up icon 2.64%
$400.52
price up icon 5.27%
자본화:     |  볼륨(24시간):